Xu Minjuan, Cui Jingrong, Fu Hongzheng, Proksch Peter, Lin Wenhan, Li Min
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Xueyuan Road 38, 100083 Beijing, P.R. China.
Planta Med. 2005 Oct;71(10):944-8. doi: 10.1055/s-2005-871250.
Biological activities of the 1,4-benzoquinone derivatives 5- O-ethylembelin ( 1) and 5- O-methylembelin ( 2) were investigated. Both of them showed antiproliferative activity against a panel of human tumor cell lines upon comparison to normal marsupial kidney cells (PtK2). They arrested HL-60 cells in the G(0)/G(1) phase of the cell cycle in a dose- and time-dependent manner. In HeLa cells, exposure to 100 microM of 1 or 2 for 6 h induced a complete disassembly of the microtubule network and an increased number of cells blocked in mitotic stages. Treatment with 10 microM of 1 and 2 for 24 h induced apoptosis in HL-60 cells. This evidence suggests that both 1 and 2 are promising novel antimitotic and anticancer molecules targeting microtubular proteins.
对1,4 - 苯醌衍生物5 - O - 乙基紫铆因(1)和5 - O - 甲基紫铆因(2)的生物活性进行了研究。与正常有袋动物肾细胞(PtK2)相比,它们对一组人类肿瘤细胞系均表现出抗增殖活性。它们以剂量和时间依赖性方式使HL - 60细胞停滞在细胞周期的G(0)/G(1)期。在HeLa细胞中,用100 microM的1或2处理6小时会导致微管网络完全解体,并使处于有丝分裂阶段的细胞数量增加。用10 microM的1和2处理24小时会诱导HL - 60细胞凋亡。这一证据表明,1和2都是有前景的新型抗有丝分裂和抗癌分子,靶向微管蛋白。